Elevated peripheral blood glutamate levels in major depressive disorder

References

• KesslerRCBerglundPDemlerONational Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• DeanJKeshavanMThe neurobiology of depression: an integrated viewAsian J Psychiatr20172710111128558878
   PubMed Web of Science ®Google Scholar
• LangUEBorgwardtSMolecular mechanisms of depression: perspectives on new treatment strategiesCell Physiol Biochem201331676177723735822
   PubMed Web of Science ®Google Scholar
• SanacoraGZarateCAKrystalJHTargeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNat Rev Drug Discov20087542643718425072
   PubMed Web of Science ®Google Scholar
• HashimotoKEmerging role of glutamate in the pathophysiology of major depressive disorderBrain Res Rev200961210512319481572
   PubMed Web of Science ®Google Scholar
• MurroughJWAbdallahCGMathewSJTargeting glutamate signalling in depression: progress and prospectsNat Rev Drug Discov201716747248628303025
   PubMed Web of Science ®Google Scholar
• MlyniecKZinc in the glutamatergic theory of depressionCurr Neuropharmacol201513450551326412070
   PubMed Web of Science ®Google Scholar
• DumanRSNeuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depressionDialogues Clin Neurosci200911323925519877493
   PubMedGoogle Scholar
• HashimotoKThe role of glutamate on the action of antidepressantsProg Neuropsychopharmacol Biol Psychiatry20113571558156820600468
   PubMed Web of Science ®Google Scholar
• TokitaKYamajiTHashimotoKRoles of glutamate signaling in preclinical and/or mechanistic models of depressionPharmacol Biochem Behav2012100468870421536063
   PubMed Web of Science ®Google Scholar
• KüçükibrahimoğluESayginMZCalişkanMThe change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depressionEur J Clin Pharmacol200965657157719373461
   PubMed Web of Science ®Google Scholar
• MaesMVerkerkRVandoolaegheESerum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivityActa Psychiatr Scand19989743023089570492
   PubMed Web of Science ®Google Scholar
• RomeoBChouchaWFossatiPMeta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depressionPsychiatry Res2015230268268826548981
   PubMed Web of Science ®Google Scholar
• UmeharaHNumataSWatanabeSYAltered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorderSci Rep201771485528687801
   PubMed Web of Science ®Google Scholar
• AltamuraCAMauriMCFerraraAPlasma and platelet excitatory amino acids in psychiatric disordersAm J Psychiatry199315011173117338214185
   PubMed Web of Science ®Google Scholar
• MauriMCFerraraABoscatiLPlasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatmentNeuropsychobiology19983731241299597668
   PubMed Web of Science ®Google Scholar
• MitaniHShirayamaYYamadaTCorrelation between plasma levels of glutamate, alanine and serine with severity of depressionProg Neuropsychopharmacol Biol Psychiatry20063061155115816707201
   PubMed Web of Science ®Google Scholar
• WooHIChunMRYangJSPlasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitorsCNS Neurosci Ther201521541742425611566
   PubMed Web of Science ®Google Scholar
• OgawaSKogaNHattoriKPlasma amino acid profile in major depressive disorder: analyses in two independent case-control sample setsJ Psychiatr Res201896233228950111
   PubMed Web of Science ®Google Scholar
• AltamuraCMaesMDaiJPlasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depressionEur Neuropsychopharmacol19955 Suppl71758775762
   PubMed Web of Science ®Google Scholar
• XuHBFangLHuZCPotential clinical utility of plasma amino acid profiling in the detection of major depressive disorderPsychiatry Res20122002–31054105722749229
   PubMed Web of Science ®Google Scholar
• Mayoral-MarilesACruz-RevillaCVega-ManriquezXPlasma amino acid levels discriminate between control subjects and mildly depressed elderly womenArch Med Res201243537538222871334
   PubMed Web of Science ®Google Scholar
• LuYRFuXYShiLGDecreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorderBMC Psychiatry20141412324767108
   PubMed Web of Science ®Google Scholar
• HashimotoKYoshidaTIshikawaMIncreased serum levels of serine enantiomers in patients with depressionActa Neuropsychiatr201628317317826512905
   PubMed Web of Science ®Google Scholar
• HashimotoKSawaAIyoMIncreased levels of glutamate in brains from patients with mood disordersBiol Psychiatry200762111310131617574216
   PubMed Web of Science ®Google Scholar
• SanacoraGGueorguievaREppersonCNSubtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depressionArch Gen Psychiatry200461770571315237082
   PubMed Web of Science ®Google Scholar
• ArnoneDMumuniANJauharSIndirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrationsEur Neuropsychopharmacol20152581109111726028038
   PubMed Web of Science ®Google Scholar
• LevineJPanchalingamKRapoportAIncreased cerebrospinal fluid glutamine levels in depressed patientsBiol Psychiatry200047758659310745050
   PubMed Web of Science ®Google Scholar
• HashimotoKBrunoDNierenbergJAbnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up studyTransl Psychiatry20166e74426926880
   PubMed Web of Science ®Google Scholar
• FryeMATsaiGEHugginsTLow cerebrospinal fluid glutamate and glycine in refractory affective disorderBiol Psychiatry2007611016216616735030
   PubMed Web of Science ®Google Scholar
• GarakaniAMartinezJMYehudaRCerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatmentJ Affect Disord2013146226226522840611
   PubMed Web of Science ®Google Scholar
• NishiANumataSTajimaAMeta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophreniaSchizophr Bull20144051154116324535549
   PubMed Web of Science ®Google Scholar
• TomiokaYNumataSKinoshitaMDecreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysisJ Psychiatry Neurosci201843217005329402374
   PubMedGoogle Scholar
• WanXWangWLiuJEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141413525524443
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• PatsopoulosNAEvangelouEIoannidisJPSensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluationInt J Epidemiol20083751148115718424475
   PubMed Web of Science ®Google Scholar
• ShulmanYGrantSSeresPThe relation between peripheral and central glutamate and glutamine in healthy male volunteersJ Psychiatry Neurosci200631640641017136218
   PubMed Web of Science ®Google Scholar